Our Services
Medical Information
Helpful Resources
Published on: 1/13/2026
Farxiga 10 mg is used to help control blood sugar in adults with type 2 diabetes, to lower the risk of cardiovascular death and hospitalization in heart failure with reduced ejection fraction, and to slow the progression of chronic kidney disease and reduce kidney or cardiovascular events, even in people without diabetes. There are several factors to consider, including who should not use it, potential side effects like genital or urinary infections and rare ketoacidosis, drug interactions, and needed monitoring. See the complete details below to guide your next steps and know when to contact a clinician.
Farxiga (dapagliflozin) 10 mg is a prescription medication belonging to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. It works by helping the kidneys remove excess glucose (sugar) from the bloodstream through urine. Beyond its role in blood sugar control, Farxiga has demonstrated significant benefits in heart and kidney health.
Type 2 Diabetes Mellitus
• As an adjunct to diet and exercise to improve glycemic control.
• Often prescribed when first-line therapies (e.g., metformin) are inadequate.
Heart Failure with Reduced Ejection Fraction (HFrEF)
• Based on the DAPA-HF trial (McMurray et al., Lancet 2019), Farxiga reduced the risk of cardiovascular death and hospitalization for heart failure in patients with an ejection fraction ≤ 40%.
• Benefits seen regardless of whether a patient has diabetes.
Chronic Kidney Disease (CKD)
• The DAPA-CKD trial (Heerspink et al., N Engl J Med 2020) showed Farxiga slowed kidney function decline and lowered the risk of kidney failure or death in patients with CKD, with or without type 2 diabetes.
DAPA-HF (McMurray JJV et al., 2019):
• Population: Patients with HFrEF, mean age ~66 years
• Outcome: 26% relative risk reduction in CV death or heart failure hospitalization
DAPA-CKD (Heerspink HJL et al., 2020):
• Population: CKD patients, eGFR 25-75 mL/min/1.73 m², elevated albuminuria
• Outcome: 39% relative risk reduction in composite of sustained decline in kidney function, end-stage kidney disease, or renal/CV death
Always report signs of serious reactions—such as rapid breathing, confusion, severe abdominal pain, or signs of infection—to your healthcare provider immediately.
If you experience:
…you should speak to a healthcare professional without delay. You might also consider doing a free, online symptom check for to help you decide whether urgent care is needed.
Farxiga can offer benefits for diabetes, heart failure, and kidney disease, but it’s not right for everyone. Always discuss:
Never stop or change your dose of Farxiga without your doctor’s approval.
Remember: This information is for educational purposes and does not replace professional medical advice. If you’re experiencing life-threatening symptoms or serious concerns, please call your doctor or emergency services immediately.
(References)
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.